HDAC9 and thyroid cancer: However, in the review by Russo et al. [70], the authors concluded that HDAC inhibitors “are emerging as very promising drugs for this purpose,” and that controlled clinical studies are needed to support a role of HDAC inhibitors in patients with thyroid cancer and who need more advanced treatment in addition to surgery and radioiodine.